Bernadette G van den Hoogen Selected Research

Therapeutics

1/2022	Optimizing environmental safety and cell-killing potential of oncolytic Newcastle Disease virus with modifications of the V, F and HN genes.
1/2015	Oncolytic viruses: From bench to bedside with a focus on safety.
8/2014	Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bernadette G van den Hoogen Research Topics

Disease

6	Infections 08/2013 - 04/2007
3	Neoplasms (Cancer) 01/2022 - 01/2015
2	Virus Diseases (Viral Diseases) 12/2020 - 01/2019
1	COVID-19 01/2021
1	Coronavirus Infections 08/2014
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 08/2014
1	Respiratory Tract Diseases (Respiratory Tract Disease) 08/2008
1	Hypersensitivity (Allergy) 12/2007
1	Respiratory Sounds (Crackle) 04/2007
1	Respiratory Tract Infections (Respiratory Tract Infection) 07/2004

Drug/Important Bio-Agent (IBA)

2	VaccinesIBA 08/2008 - 07/2008
2	Neutralizing AntibodiesIBA 10/2007 - 04/2007
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2020
1	RNA (Ribonucleic Acid)IBA 01/2019
1	LigandsIBA 01/2019
1	Pharmaceutical PreparationsIBA 08/2014
1	Antiviral Agents (Antivirals)IBA 08/2013
1	Viral RNAIBA 08/2013
1	Formaldehyde (Formol)FDA Link 12/2007
1	Subunit VaccinesIBA 10/2007
1	DNA (Deoxyribonucleic Acid)IBA 04/2007
1	EnzymesIBA 07/2004
1	ImmunosorbentsIBA 07/2004

Therapy/Procedure

3	Therapeutics 01/2022 - 08/2014
1	Length of Stay 01/2021
1	Immunotherapy 01/2015